SavedAdd your journal

Journals / Bozok Tıp Dergisi / 2013 / Cilt: 3 - Sayı: 3

Clinical Outcomes of Radioactive Iodine Therapy in a Patient with Myasthenia Gravis and Hyperthyroidism

Mustafa UĞUR
Cumali GÖKÇE
İhsan ÜSTÜN
Seçkin AKKÜÇÜK
Füsun AYDOĞAN
Akın AYDOĞAN
Pages
69–71
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Radioactive iodine therapy was applied to the patient and after 3 months of medication the patient become euthyroid and clinical findings of myasthenia were regressed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Myasthenia Gravis is an autoimmune disease characterized with muscle weakness and fatigue.
📊
Key Findings & Data:Hyperthyroidism can be present with Myasthenia Gravis with a rate of 2-17.5 %.
💡
Conclusion & Impact:Radioactive iodine therapy was applied to the patient and after 3 months of medication the patient become euthyroid and clinical findings of myasthenia were regressed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Myasthenia Gravis is an autoimmune disease characterized with muscle weakness and fatigue. Hyperthyroidism can be present with Myasthenia Gravis with a rate of 2-17.5 %. It is known that hyperthyroidism affects the clinical course of myasthenia gravis. A 27 years old woman with myasthenia gravis and recently occurred hyperthyroidism is presented in this study. Radioactive iodine therapy was applied to the patient and after 3 months of medication the patient become euthyroid and clinical findings of myasthenia were regressed.

🔖

Cite This Article

UĞUR, M., GÖKÇE, C., ÜSTÜN, İ., AKKÜÇÜK, S., AYDOĞAN, F., AYDOĞAN, A. (2022). Clinical Outcomes of Radioactive Iodine Therapy in a Patient with Myasthenia Gravis and Hyperthyroidism. Bozok Tıp Dergisi, Cilt: 3 - Sayı: 3, 69–71. https://ajindex.com/articles/468992

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Drachman DB. Myasthenia gravis. N Engl J Med 1994;330:1797-810
  2. Ratanakorn D, Vejjajiva A. Long-term follow-up of myasthenia gravis patients with hyperthyroidism. Acta Neurol Scand 2002;106(2):93-8
  3. Marinó M, Ricciardi R, Pinchera A, Barbesino G, Manetti L, Chiovato L, Braverman LE, Rossi B, Muratorio A, Mariotti S.Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases. J Clin Endocrinol Metab 1997; 82(2):438-43
  4. Datt V, Tempe DK, Singh B, Tomar AS, Banerjee A, Dutta D, Bhandari H.Anesthetic management of patient with myasthenia gravis and uncontrolled hyperthyroidism for thymectomy. Ann Card Anaesth 2010;13(1):49-52
  5. Trabelsi L, Charfi N, Triki Ch, Mnif M, Rekik N, Mhiri Ch, Abid M. Myasthenia gravis and hyperthyroidism: two cases. Ann Endocrinol (Paris) 2006;67(3):265-9
  6. Moura-Neto A, Mosci C, Santos AO, Amorim BJ, de Lima MC, Etchebehere EC, Tambascia MA, Ramos CD, Zantut-Wittmann DE. Predictive factors of failure in a fixed 15 mCi 131I-iodide therapy for Graves’ disease. Clin Nucl Med 2012;37(6):550-4
  7. Freedman S.Antisemitism and the history of myasthenia gravis. Isr Med Assoc J 2010;12(4):195-8 8. Waller E.E, Razavi M, Picchi J. Myasthenia Gravis and Hyperthyroidism—A Report of Two Cases Calif Med 1963;99(5): 340–3
  8. Weetman Ap. Graves’ Dis. N Engl J Med 2000;343: 1236–48
  9. Knapska-Kucharska M, Oszukowska L, Lewiński A. Analysis of demographic and clinical factors affecting the outcome of radioiodine therapy in patients with hyperthyroidism Arch Med Sci 2010;6(4):611-6.